Recent literature has reported on poor influenza vaccination rates in children with chronic diseases. However, little is known about specific data for children with asthma and cystic fibrosis. Therefore, the current study assessed the seasonal influenza vaccination coverage level for the 2020â2021 season compared with the routine vaccination coverage [1].
Paediatric patients older than 6 months diagnosed with asthma or cystic fibrosis were included in the study that took place in a respiratory clinic in Greece. Parents were asked to fill in a questionnaire and to share the vaccination status. Telephone interviews were held to gather information on withdrawal of vaccination. The study was performed from October to December 2020.
Participants were children with cystic fibrosis (n=63) and asthma (n=41) with a mean age of 14.3 and 12.3 years, respectively. Slightly more boys (54%) than girls were included. The influenza vaccination rate for cystic fibrosis was 94% compared with 59% for asthma (P<0.05). The vaccination rates for routine vaccines were higher: 100% of asthma patients were vaccinated against hepatitis B, DTPCaHi, conjugate pneumococcal, and measles, mumps, and rubella. Of cystic fibrosis patients, 73% were vaccinated with the polysaccharide pneumococcal vaccine. Parents reported to have been informed by clinicians about the vaccination recommendations, including the influenza vaccine, in 96% of cystic fibrosis and 83% of asthma patients.
In short, despite physiciansâ vaccination counselling, a significant difference was found in the seasonal influenza vaccine coverage between cystic fibrosis and asthma patients. More research is needed to understand motivators and barriers to vaccinate children with chronic respiratory disease.
- Hatziagorou E, et al. Influenza vaccination in children with high-risk chronic diseases. Abstract 3146. ERS 2021, 5â8 September.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Better lung function in children with a healthy diet Next Article
The effect of the pandemic on the discharge diagnosis of older COPD patients »
« Better lung function in children with a healthy diet Next Article
The effect of the pandemic on the discharge diagnosis of older COPD patients »
Table of Contents: ERS 2021
Featured articles
Letter from the Editor
COVID-19 Research: Looking Back and Moving Forward
Higher inflammation markers in COVID-19 patients with a first negative PCR test
Persistent fatigue following COVID-19
Risk of COVID-19-related morbidity and mortality in young and middle-aged adults
Respiratory Viral Infections: Insights from Recent Studies
Rhinovirus bronchiolitis increased risk of recurrent wheezing and asthma
COPD: Evidence Update
Livestock farming affected the airway microbiome of COPD patients
Reduction of COPD severe acute exacerbations by candidate vaccine
Paediatrics and Vaccinology
Better lung function in children with a healthy diet
Need for validated severity score in the assessment of bronchiolitis
Increased impact of air pollution on lung function in preterm infants
Pearls in Asthma Research
Biomarkers do not discriminate severe from severe uncontrolled asthma
Increased blood neutrophiles in patients with obesity and asthma
Blood inflammatory phenotypes associated with clinical symptoms of asthma
Related Articles
July 16, 2021
Breath biomarkers validated for obstructive sleep apnea
November 7, 2018
ICS: to use or not to use?
August 17, 2022
Tailored exercise needed for COPD patients
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com